Artificial intelligence is accelerating drug development and lowering costs across the pharmaceutical industry, potentially boosting operating profits by more than 10%, according to Bernstein.
Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...
In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...
Pharmaceutical companies have been at the forefront of artificial intelligence for quite some time. Researchers have been using advanced AI models to understand disease mechanisms even before the ...
Government and private capital should strengthen cooperation with such funds to support innovative drug development and accelerate the commercialization of new technologies, Ding said. "This would ...
Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than ...
At the end of January 2026, AstraZeneca, a Swedish-British pharmaceutical and biotechnology company, announced its re-entry into China's pharmaceutical market with a $15 billion investment over the ...
Pharma and Biopharma is a trillion-dollar industry providing ample career opportunities for laboratory scientists and entrepreneurs. Join Principal Consultant Michael W. Dong of MWD Consulting as he ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果